Tauvid

Active Ingredient(s): Flortaucipir F-18
FDA Approved: * May 28, 2020
Pharm Company: * AVID RADIOPHARMS INC
Category: Diagnostic Aid

Flortaucipir (18F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain.[1][2][3] The most common adverse reactions include headache, injection site pain and increased blood pressure.[1][2] Two proteins – tau and amyloid – are recognized as hallmarks of Alzheimer's disease.[1] In people ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tauvid 51 mci/Ml Intravenous Injection, Solution
NDC: 0002-1210
Labeler:
Eli Lilly and Company
Tauvid 100 mci/Ml Intravenous Injection, Solution
NDC: 0002-1220
Labeler:
Eli Lilly and Company